Weiner Daniel E, Kapoian Toros, Johnson Douglas S
aDivision of Nephrology, Tufts University School of Medicine bTufts Medical Center, Boston, Massachusetts cRutgers-Robert Wood Johnson Medical School, Department of Medicine, Division of Nephrology dDialysis Clinic, Inc., North Brunswick, New Jersey eDialysis Clinic Inc., Nashville, Tennessee, USA.
Curr Opin Nephrol Hypertens. 2015 Nov;24(6):546-56. doi: 10.1097/MNH.0000000000000173.
The role of nutrition and nutritional supplementation in dialysis recently has been reinvigorated, with small clinical trials exploring surrogate outcomes and larger epidemiologic studies generating treatment hypotheses requiring further study. The present review focuses on major aspects of nutrition and outcomes in hemodialysis patients: protein and calorie intake and nutritional vitamin D supplementation.
Building on data from small studies, two large, quasi-experimental cohort studies showed significant mortality benefits associated with oral nutritional supplements provided during dialysis, suggesting potential options for ameliorating the protein-energy wasting that is common in dialysis patients and associated with poor outcomes. Multiple cohort studies suggest, both in the general population and in dialysis, that higher 25(OH) vitamin D levels are associated with improved outcomes; however, no major mortality trials exist in dialysis, and the smaller, surrogate studies conducted to date have been disappointing, showing no consistent benefits in surrogate outcomes including inflammation and anemia, despite appropriate responses of vitamin D levels to repletion.
Nutritional interventions are attractive options for improving outcomes in dialysis patients. Nutritional protein supplements have considerable promise, but require further study, preferably in a large, generalizable pragmatic trial. Small nutritional vitamin D supplementation trials in dialysis have had disappointing results. In the absence of new data, there appears to be no role for routine assessment or repletion of 25(OH) vitamin D deficiency or insufficiency in dialysis.
营养及营养补充剂在透析中的作用近来再度受到关注,小型临床试验探索替代结局,大型流行病学研究则提出了需要进一步研究的治疗假设。本综述聚焦于血液透析患者营养及结局的主要方面:蛋白质和热量摄入以及营养性维生素D补充。
基于小型研究的数据,两项大型半实验性队列研究表明,透析期间提供口服营养补充剂可显著降低死亡率,这为改善透析患者中常见且与不良结局相关的蛋白质 - 能量消耗提供了潜在选择。多项队列研究表明,在普通人群和透析患者中,较高的25(OH)维生素D水平均与更好的结局相关;然而,透析领域尚无大型死亡率试验,且迄今为止进行的较小规模替代结局研究令人失望,尽管补充维生素D后其水平有适当反应,但在包括炎症和贫血在内的替代结局方面未显示出一致的益处。
营养干预是改善透析患者结局的有吸引力的选择。营养性蛋白质补充剂前景可观,但需要进一步研究,最好是进行大规模、可推广的实用性试验。透析中维生素D小剂量补充试验结果令人失望。在缺乏新数据的情况下,似乎没有必要对透析患者常规评估或补充25(OH)维生素D缺乏或不足。